| dc.contributor.author | Khairy, H. | |
| dc.contributor.author | Houssen, Wael E | |
| dc.date.accessioned | 2013-02-11T11:38:00Z | |
| dc.date.available | 2013-02-11T11:38:00Z | |
| dc.date.issued | 2010-01-01 | |
| dc.identifier | 20046078 | |
| dc.identifier | eb16ab7e-962a-4121-a0ca-220cf2df612f | |
| dc.identifier | 78650319514 | |
| dc.identifier.citation | Khairy , H & Houssen , W E 2010 , ' Inactivation of anandamide signaling : A continuing Debate ' , Pharmaceuticals , vol. 3 , no. 11 , pp. 3355-3370 . https://doi.org/10.3390/ph3113355 | en |
| dc.identifier.issn | 1424-8247 | |
| dc.identifier.uri | http://hdl.handle.net/2164/2629 | |
| dc.description | Copyright 2011 Elsevier B.V., All rights reserved. | en |
| dc.format.extent | 16 | |
| dc.format.extent | 190383 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Pharmaceuticals | en |
| dc.subject | endocannabinoid inactivation | en |
| dc.subject | anandamide | en |
| dc.subject | ethanolamine | en |
| dc.subject | RM Therapeutics. Pharmacology | en |
| dc.subject.lcc | RM | en |
| dc.title | Inactivation of anandamide signaling : A continuing Debate | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | 10.3390/ph3113355 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=78650319514&partnerID=8YFLogxK | en |
